Skip to main content
TipRanks
Go Ultimate75% OFF
RQ Biotechnology Ltd logo

RQ Biotechnology Ltd: Valuation, Funding & Investors

Lynton House, Tavistock Square London, England, GBhttps://www.rqbiotechnology.com/Therapeutics

RQ Biotechnology Ltd (RQ Bio) is a biotechnology company focused on passive immunization, developing potent broad-spectrum monoclonal antibodies (mAbs) to provide immediate and durable protection against viral infections. The company partners with pharmaceutical organizations to discover and advance antibody-based medicines aimed at protecting populations for whom vaccines are ineffective or insufficient, including those at high risk of severe disease from current and future viral threats.

Leadership & Board

Key Executives

Founder
Jane Osbourn OBE
Founder
Paul Kellam
Current Number of Employees
20
Current LinkedIn Followers
4,552

Latest Estimated Valuation

Total Amount Raised
$115M
Total Funding Rounds
1
Latest Funding Amount
$115M
Latest Funding Round
Series A

Employee Trend

RQ Biotechnology Ltd had 20 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

20Latest Employee Count
0(0.00%)Week-Over-Week Change
05101520Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

RQ Biotechnology Ltd had 4,552 followers as of November 16, 2026. The number of followers increased by 174 (3.97%) week-over-week.

4,552Latest Followers Count
174(3.97%)Week-Over-Week Change
02,0004,0006,0008,000Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jul 01, 2026Series A$115.00M―

Similar Companies

A snapshot of private companies similar to RQ Biotechnology Ltd, helping you discover and navigate related company profiles.

Related News and Analysis